Study Details
- Type: Research
- Disease: COPD and Comorbid Complex Chronic Conditions (CCCs)
- Sites: The Netherlands, Italy, Estonia
- Start: March 2021
- Population: 710 patients
- Duration: 48 months
Study Description
Shared-decision making for tailored Comorbid Complex Chronic (CCC) disease management, crossing care paths towards daily life, and early proper treatment to prevent CCC disease progression. Identify individual multi-morbid CCC exacerbations and develop tailored referrals to a multidisciplinary, adaptive virtual companionship program for COPD patients with CCCs.
The RWD from daily life measurements and existing medical knowledge-base will be integrated based on inclusive models representing e.g. patients, healthcare (providers), scientists, policymakers, and industry. The RE-SAMPLE study develop privacy-securing data management and AI prediction modeling to tailor local personalised treatment programs using accurate predictions of multi-morbid exacerbations and personalised interventions.
Study Design & Method
Patients will receive an activity tracker (i.e monitoring bracelet) that will collect at a daily basis Real-World Data like activity (i.e. steps per day), sleep, and vital signs. The device will be delivered during the recruitment, and each patient/participant will pair the device through the Healthentia application downloaded on the smartphone.
During the whole observation period, patients will report through weekly dedicated questionnaires for RWD collection and management mechanisms. Also, the study aims to implement and test the real-time predictions of the RE-SAMPLE-trained models applied to new data.
RWD to monitor COPD symptoms beyond scheduled medical check-ups
Personalised treatment and a virtual companionship programme
Multidisciplinary approach (respiratory medicine, AI, RWD, privacy, ethics, data protection, health policy)
